↓ Skip to main content

Dove Medical Press

Article Metrics

Clinical Management of Relapsed/Refractory Hemophagocytic Lymphohistiocytosis in Adult Patients: A Review of Current Strategies and Emerging Therapies

Overview of attention for article published in Therapeutics and Clinical Risk Management, April 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
6 Mendeley
Title
Clinical Management of Relapsed/Refractory Hemophagocytic Lymphohistiocytosis in Adult Patients: A Review of Current Strategies and Emerging Therapies
Published in
Therapeutics and Clinical Risk Management, April 2021
DOI 10.2147/tcrm.s195538
Authors

Halil Yildiz, Sarah Bailly, Eric Van Den Neste, Jean Cyr Yombi

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Professor 1 17%
Student > Doctoral Student 1 17%
Unknown 4 67%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 17%
Unknown 5 83%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 April 2021.
All research outputs
#10,642,880
of 17,726,748 outputs
Outputs from Therapeutics and Clinical Risk Management
#585
of 1,107 outputs
Outputs of similar age
#143,841
of 277,834 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#2
of 2 outputs
Altmetric has tracked 17,726,748 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,107 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 277,834 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.